Vascular Access Technologies, Inc


Vascular Access Technologies has developed SAFECVAD, the world's first patented retrograde central venous access catheter. Every year in the US, there are more than 150,000 severe complications and 11,000 people die to to complications associated with central venous access. The market size is $1.5B and the affordable care act specifically lists the complications that SAFECVAD solves.

Video Pitch

Management Team


Jim Archetto

25+ years of successful medical device expertise and leadership, including 4 start-ups. The most successful, Radi Medical Systems wast acquired by St. Jude Medical for $250M

Founder, Vascular Access Technologies, Inc.

Lakshmikumar Pillai

Dr. Pillai is Chief of Vascular and Endovascular Surgery at West Virginia University founder of Vascular Access Technologies, Inc, and inventor of SAFECVAD.